title: The effect of pre-eclampsia on coagulation and fibrinolytic activation in the neonate.
authors.affiliation: Rotunda Hospital, Dublin, Ireland. j.higgins@obsgyn-mercy.unimelb.edu.au
authors.forename: J R
authors.initials: JR
authors.lastname: Higgins
authors.forename: J
authors.initials: J
authors.lastname: Bonnar
authors.forename: L A
authors.initials: LA
authors.lastname: Norris
authors.forename: M R
authors.initials: MR
authors.lastname: Darling
authors.forename: J J
authors.initials: JJ
authors.lastname: Walshe
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D000933:Antifibrinolytic Agents / Q000097:blood; D000990:Antithrombin III / Q000378:metabolism; D001724:Birth Weight; D001777:Blood Coagulation / Q000502:physiology*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005338:Fibrin Fibrinogen Degradation Products; D005342:Fibrinolysis / Q000502:physiology*; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D010447:Peptide Hydrolases / Q000378:metabolism; D011225:Pre-Eclampsia / Q000097:blood / Q000503:physiopathology; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000378:metabolism
chemical_list: D000933:Antifibrinolytic Agents; D005338:Fibrin Fibrinogen Degradation Products; C046193:antithrombin III-protease complex; C036309:fibrin fragment D; D000990:Antithrombin III; D010447:Peptide Hydrolases